Kerching! £30 million for Avocet top brass

by EWAN LAMB

Two executive directors of Avocet Natural Capital PLC together with an American-based chemical specialist are due to receive a total of £30 million once the complicated network of trade deals for the sale of intellectual property is concluded.

The payments, which will see 'controversial Anglo-Irish businessman' Martin Frost, Dr. Bob Jennings and Dr Glyn Short become multi-millionaires, have been revealed in a newsletter from Mr Frost to shareholders of ANC and its associate company Gennfros Ltd.

It means the patents said to be held by both companies, and which largely depend on a 'revolutionary' brand of so-called avocet fuel will be traded without a single product having been brought to the market during Avocet's seven year existence.

The correspondence from Mr Frost to investors also makes further reference to P C H, the mysterious offshore company prepared to plough £400 million into Gennfros although few people appear to have heard of the corporation. None of the directors of P C H have been named, and there is no contact address or telephone number on press releases.

However, Mr Frost now claims PCH is an acronym interfacing four offshore investor companies.

"It is a published fact that the principals behind PCH have purchased some £2.5 billion pounds of third-party intellectual property in the last 10 years – a £150 million offer for Gennfros Limited’s and £60 million offer for Avocet IP Limited is relative."

Subsequent information from Mr Frost tends to show that P C H has practically assumed ownership of a number of companies, including insolvent 'Avocet' businesses.

He states: "On Omega Infinite Plc formerly Avocet Infinite Plc [now in liquidation] PCH has acquired some 50% of the share equity; PCH has acquired 100% of the share equity of Orrdone Farms Limited [now in administration]; On Bio Solutions formerly Avocet Bio-Solutions Plc PCH has acquired over 50% of the equity.

"On Avocet Natural Capital Plc (with subsidiary Avocet IP Limited): Despite real threats to block an intellectual property sale by Avocet IP Limited: 4pm Texas time (UK 10 pm) on 31st May was the final time that a ‘bad person’ under Texas law could seek to intervene to block Avocet IP Limited’s $100 million US dollar intellectual property Texan sale. It is now a question of mechanics and sorting tax matters before ANC Plc and Gennfros Limited shareholders receive their dividend.

"The directors of ANC Plc and Gennfros Limited have agreed that Gennfros Limited now purchases Avocet IP Limited from ANC Plc for £60 million pounds sterling and that thereafter ANC Plc is dissolved thereby releasing approximately £1 pound sterling back to each bona fide ANC Plc shareholder by September 1st, 2021."

Mr Frost goes on to disclose exactly how much Avocet's major players stand to gain from the IP sales and share dealings.

"To avoid confusion & back biting. Dr. Glyn Short & family is due to receive some £8 million from these transactions. Dr. ‘Bob’ Jennings & family is due to receive some £9 million from these transactions. Martin Frost & family is due to receive some £13 million from these transactions".

He adds that all other ANC Plc shareholders 'are well rewarded as to their equity investment'.

"On Gennfros Limited - The Confirmation Statement witnesses, PCH now owns 14 million Gennfros Limited shares with firm options to acquire a further 6 million + bonded voting agreements with another 7 million. On June 2nd PCH makes further conditional offers.

"The Frost family has a £12 million consideration in respect of 4 million Gennfros Limited shares to the Russian investor re PCH: Парашютные Холдинги OOO."

An observer told us: "That Russian company’s name translates to “Parachute Holdings” according to Google, probably a very appropriate name!"